{"id":{"repo_id":"rice","oai_identifier":"oai:repository.rice.edu:1911/16737"},"canonical_url":"https://search.dev.ndltd.org/etd/rice/oai:repository.rice.edu:1911/16737","repository":{"repo_id":"rice","name":"Rice University","base_url":"https://repository.rice.edu/server/oai/request"},"display":{"title":"Syntheses, bioactivities and conformations of peptidomimetics containing 2,3-methanoamino acids","abstract":"Asymmetric syntheses of E- and Z-2,3-methanomethionine (ie E- and Z-cyclo-Met), protected Z-2,3-methanoarginine, and Z-2,3-methanoaspartic acid derivatives have been developed. These functionalized 2,3-methanoamino acids were prepared from a common intermediate: 1- ((tert-butoxy)carbonyl) -2-oxo-3-oxa-bicyclo (3.1.0) hexane. Peptidomimetics containing some of these 2,3-methanoamino acids mentioned above were synthesized via a solid phase approach. The Met$\\sp2$ in neuropeptide Phe-Met-Arg-Phe-NH$\\sb2$ (FMRF-NH$\\sb2$, one letter code for amino acids) was systematically replaced by each of the isomers of cyclo-Met giving four peptidomimetics, namely F$\\{$2S,3R-cyclo-M$\\}$RF-NH$\\sb2$, F$\\{$2R,3S-cyclo-M$\\}$RF-NH$\\sb2$, F$\\{$2S,3S-cyclo-M$\\}$RF-NH$\\sb2$ and F$\\{$2R,3R-cyclo-M$\\}$RF-NH$\\sb2$. A peptidomimetic containing two 2,3-methanoamino acids substituted in the 2 and 4 positions (ie F$\\{$2S,3S-cyclo-M$\\}$R$\\{$2R,3R-cyclo-F$\\}$-NH$\\sb2$) was also prepared. Generally, 2,3-methanoamino acids are compatible with solid phase chemistry, although they are more sterically hindered than their corresponding natural amino acids. Anti-opiate activities, and proteolytic stabilities of the peptidomimetics were studied. The peptidomimetics were more active (in vivo) than the FMRF-NH$\\sb2$ but bind less strongly to the appropriate receptor sites. This observation seems to be related to the enhanced bio-availability of the peptidomimetics, because the F$\\{$E-cyclo-M$\\}$RF-NH$\\sb2$ analogs were much more proteolytically stable than the parent peptide with respect to leucine aminopeptidase digestion. Solution conformations of the peptidomimetics were investigated by NMR. Incorporation of 2,3-methanoamino acids into peptides induced NMR observable conformational rigidity. This was evident from: (i) interresidue ROE crosspeaks centered at the methanologs; (ii) unusual chemical shifts and temperature coefficients of some NH signals; and, (iii) line boardening for F$\\{$2S,3S-cyclo-M$\\}$R$\\{$2R,3R-cyclo-F$\\}$-NH$\\sb2$ in the $\\sp1$H-NMR spectrum. The NMR data was correlated with the structures obtained from quenched molecular dynamics (QMD), which was performed by using a set of empirical parameters. Structures obtained from the QMD studies gave good correlation with the experimental data. Defined secondary structure ($\\gamma$-turn) was observed for peptidomimetic F$\\{$2S,3S-cyclo-M$\\}$RF-NH$\\sb2$.","abstract_html":"Asymmetric syntheses of E- and Z-2,3-methanomethionine (ie E- and Z-cyclo-Met), protected Z-2,3-methanoarginine, and Z-2,3-methanoaspartic acid derivatives have been developed. These functionalized 2,3-methanoamino acids were prepared from a common intermediate: 1- ((tert-butoxy)carbonyl) -2-oxo-3-oxa-bicyclo (3.1.0) hexane. Peptidomimetics containing some of these 2,3-methanoamino acids mentioned above were synthesized via a solid phase approach. The Met$\\sp2$ in neuropeptide Phe-Met-Arg-Phe-NH$\\sb2$ (FMRF-NH$\\sb2$, one letter code for amino acids) was systematically replaced by each of the isomers of cyclo-Met giving four peptidomimetics, namely F$\\{$2S,3R-cyclo-M$\\}$RF-NH$\\sb2$, F$\\{$2R,3S-cyclo-M$\\}$RF-NH$\\sb2$, F$\\{$2S,3S-cyclo-M$\\}$RF-NH$\\sb2$ and F$\\{$2R,3R-cyclo-M$\\}$RF-NH$\\sb2$. A peptidomimetic containing two 2,3-methanoamino acids substituted in the 2 and 4 positions (ie F$\\{$2S,3S-cyclo-M$\\}$R$\\{$2R,3R-cyclo-F$\\}$-NH$\\sb2$) was also prepared. Generally, 2,3-methanoamino acids are compatible with solid phase chemistry, although they are more sterically hindered than their corresponding natural amino acids. Anti-opiate activities, and proteolytic stabilities of the peptidomimetics were studied. The peptidomimetics were more active (in vivo) than the FMRF-NH$\\sb2$ but bind less strongly to the appropriate receptor sites. This observation seems to be related to the enhanced bio-availability of the peptidomimetics, because the F$\\{$E-cyclo-M$\\}$RF-NH$\\sb2$ analogs were much more proteolytically stable than the parent peptide with respect to leucine aminopeptidase digestion. Solution conformations of the peptidomimetics were investigated by NMR. Incorporation of 2,3-methanoamino acids into peptides induced NMR observable conformational rigidity. This was evident from: (i) interresidue ROE crosspeaks centered at the methanologs; (ii) unusual chemical shifts and temperature coefficients of some NH signals; and, (iii) line boardening for F$\\{$2S,3S-cyclo-M$\\}$R$\\{$2R,3R-cyclo-F$\\}$-NH$\\sb2$ in the $\\sp1$H-NMR spectrum. The NMR data was correlated with the structures obtained from quenched molecular dynamics (QMD), which was performed by using a set of empirical parameters. Structures obtained from the QMD studies gave good correlation with the experimental data. Defined secondary structure (<span class=\"etd-inline-math\">&gamma;</span>-turn) was observed for peptidomimetic F$\\{$2S,3S-cyclo-M$\\}$RF-NH$\\sb2$.","abstract_has_math":true,"creators":["Ho, Kwok-Kan"],"institution":"Rice University","degree_name":"Doctor of Philosophy","degree_level":"Doctoral","degree_discipline":"Natural Sciences","degree_department":null,"school":null,"contributors":[],"advisors":["Burgess, Kevin"],"committee_chairs":[],"committee_members":[],"year":1994,"date_issued":"1994","date_published":"1994","updated_at":"2026-07-24T04:10:21Z","subjects":["Organic chemistry","Pharmaceutical chemistry","Biochemistry"],"languages":["eng"],"rights":["Copyright is held by the author, unless otherwise indicated. Permission to reuse, publish, or reproduce the work beyond the bounds of fair use or other exemptions to copyright law must be obtained from the copyright holder."],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/1911/16737","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Burgess, Kevin"]},{"key":"dc:creator","label":"Author","values":["Ho, Kwok-Kan"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2009-06-04T00:12:37Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2009-06-04T00:12:37Z"]},{"key":"dc:date.issued","label":"Date","values":["1994"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Natural Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Doctoral"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Rice University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Organic chemistry","Pharmaceutical chemistry","Biochemistry"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright is held by the author, unless otherwise indicated. Permission to reuse, publish, or reproduce the work beyond the bounds of fair use or other exemptions to copyright law must be obtained from the copyright holder."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/1911/16737"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Asymmetric syntheses of E- and Z-2,3-methanomethionine (ie E- and Z-cyclo-Met), protected Z-2,3-methanoarginine, and Z-2,3-methanoaspartic acid derivatives have been developed. These functionalized 2,3-methanoamino acids were prepared from a common intermediate: 1- ((tert-butoxy)carbonyl) -2-oxo-3-oxa-bicyclo (3.1.0) hexane. Peptidomimetics containing some of these 2,3-methanoamino acids mentioned above were synthesized via a solid phase approach. The Met$\\sp2$ in neuropeptide Phe-Met-Arg-Phe-NH$\\sb2$ (FMRF-NH$\\sb2$, one letter code for amino acids) was systematically replaced by each of the isomers of cyclo-Met giving four peptidomimetics, namely F$\\{$2S,3R-cyclo-M$\\}$RF-NH$\\sb2$, F$\\{$2R,3S-cyclo-M$\\}$RF-NH$\\sb2$, F$\\{$2S,3S-cyclo-M$\\}$RF-NH$\\sb2$ and F$\\{$2R,3R-cyclo-M$\\}$RF-NH$\\sb2$. A peptidomimetic containing two 2,3-methanoamino acids substituted in the 2 and 4 positions (ie F$\\{$2S,3S-cyclo-M$\\}$R$\\{$2R,3R-cyclo-F$\\}$-NH$\\sb2$) was also prepared. Generally, 2,3-methanoamino acids are compatible with solid phase chemistry, although they are more sterically hindered than their corresponding natural amino acids. Anti-opiate activities, and proteolytic stabilities of the peptidomimetics were studied. The peptidomimetics were more active (in vivo) than the FMRF-NH$\\sb2$ but bind less strongly to the appropriate receptor sites. This observation seems to be related to the enhanced bio-availability of the peptidomimetics, because the F$\\{$E-cyclo-M$\\}$RF-NH$\\sb2$ analogs were much more proteolytically stable than the parent peptide with respect to leucine aminopeptidase digestion. Solution conformations of the peptidomimetics were investigated by NMR. Incorporation of 2,3-methanoamino acids into peptides induced NMR observable conformational rigidity. This was evident from: (i) interresidue ROE crosspeaks centered at the methanologs; (ii) unusual chemical shifts and temperature coefficients of some NH signals; and, (iii) line boardening for F$\\{$2S,3S-cyclo-M$\\}$R$\\{$2R,3R-cyclo-F$\\}$-NH$\\sb2$ in the $\\sp1$H-NMR spectrum. The NMR data was correlated with the structures obtained from quenched molecular dynamics (QMD), which was performed by using a set of empirical parameters. Structures obtained from the QMD studies gave good correlation with the experimental data. Defined secondary structure ($\\gamma$-turn) was observed for peptidomimetic F$\\{$2S,3S-cyclo-M$\\}$RF-NH$\\sb2$."]},{"key":"dc:format.mimetype","label":"Dc Format Mimetype","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Syntheses, bioactivities and conformations of peptidomimetics containing 2,3-methanoamino acids"]}]}],"canonical_facts":{"dc:contributor.advisor":["Burgess, Kevin"],"dc:creator":["Ho, Kwok-Kan"],"dc:date.accessioned":["2009-06-04T00:12:37Z"],"dc:date.available":["2009-06-04T00:12:37Z"],"dc:date.issued":["1994"],"dc:description.abstract":["Asymmetric syntheses of E- and Z-2,3-methanomethionine (ie E- and Z-cyclo-Met), protected Z-2,3-methanoarginine, and Z-2,3-methanoaspartic acid derivatives have been developed. These functionalized 2,3-methanoamino acids were prepared from a common intermediate: 1- ((tert-butoxy)carbonyl) -2-oxo-3-oxa-bicyclo (3.1.0) hexane. Peptidomimetics containing some of these 2,3-methanoamino acids mentioned above were synthesized via a solid phase approach. The Met$\\sp2$ in neuropeptide Phe-Met-Arg-Phe-NH$\\sb2$ (FMRF-NH$\\sb2$, one letter code for amino acids) was systematically replaced by each of the isomers of cyclo-Met giving four peptidomimetics, namely F$\\{$2S,3R-cyclo-M$\\}$RF-NH$\\sb2$, F$\\{$2R,3S-cyclo-M$\\}$RF-NH$\\sb2$, F$\\{$2S,3S-cyclo-M$\\}$RF-NH$\\sb2$ and F$\\{$2R,3R-cyclo-M$\\}$RF-NH$\\sb2$. A peptidomimetic containing two 2,3-methanoamino acids substituted in the 2 and 4 positions (ie F$\\{$2S,3S-cyclo-M$\\}$R$\\{$2R,3R-cyclo-F$\\}$-NH$\\sb2$) was also prepared. Generally, 2,3-methanoamino acids are compatible with solid phase chemistry, although they are more sterically hindered than their corresponding natural amino acids. Anti-opiate activities, and proteolytic stabilities of the peptidomimetics were studied. The peptidomimetics were more active (in vivo) than the FMRF-NH$\\sb2$ but bind less strongly to the appropriate receptor sites. This observation seems to be related to the enhanced bio-availability of the peptidomimetics, because the F$\\{$E-cyclo-M$\\}$RF-NH$\\sb2$ analogs were much more proteolytically stable than the parent peptide with respect to leucine aminopeptidase digestion. Solution conformations of the peptidomimetics were investigated by NMR. Incorporation of 2,3-methanoamino acids into peptides induced NMR observable conformational rigidity. This was evident from: (i) interresidue ROE crosspeaks centered at the methanologs; (ii) unusual chemical shifts and temperature coefficients of some NH signals; and, (iii) line boardening for F$\\{$2S,3S-cyclo-M$\\}$R$\\{$2R,3R-cyclo-F$\\}$-NH$\\sb2$ in the $\\sp1$H-NMR spectrum. The NMR data was correlated with the structures obtained from quenched molecular dynamics (QMD), which was performed by using a set of empirical parameters. Structures obtained from the QMD studies gave good correlation with the experimental data. Defined secondary structure ($\\gamma$-turn) was observed for peptidomimetic F$\\{$2S,3S-cyclo-M$\\}$RF-NH$\\sb2$."],"dc:format.mimetype":["application/pdf"],"dc:identifier.uri":["https://hdl.handle.net/1911/16737"],"dc:language.iso":["eng"],"dc:rights":["Copyright is held by the author, unless otherwise indicated. Permission to reuse, publish, or reproduce the work beyond the bounds of fair use or other exemptions to copyright law must be obtained from the copyright holder."],"dc:subject":["Organic chemistry","Pharmaceutical chemistry","Biochemistry"],"dc:title":["Syntheses, bioactivities and conformations of peptidomimetics containing 2,3-methanoamino acids"],"dc:type":["Thesis"],"thesis:degree_discipline":["Natural Sciences"],"thesis:degree_level":["Doctoral"],"thesis:degree_name":["Doctor of Philosophy"],"thesis:institution_name":["Rice University"]},"updated_at":"2026-07-24T04:10:21Z"}